Digitalis glycosides.
Copyright policy )Digitalis glycosides.
The digitalis glycosides are potent cardiovascular drugs with a low therapeutic index and a high incidence of iatrogenic complications. Digoxin is the most commonly used preparation. Common indications include rate control in atrial fibrillation, as well as the treatment of other atrial tachyarrhythmias, and low-output congestive heart failure. Digitalis is contraindicated in idiopathic hypertrophic subaortic stenosis (unless atrial fibrillation is present) and in some patients with Wolff-Parkinson-White syndrome.
Digoxin, Biological Availability, Digitalis Glycosides, Arrhythmias, Cardiac, Heart, Drug Administration Schedule, Ion Channels, Stimulation, Chemical, Digitoxin, Humans, Drug Interactions
Digoxin, Biological Availability, Digitalis Glycosides, Arrhythmias, Cardiac, Heart, Drug Administration Schedule, Ion Channels, Stimulation, Chemical, Digitoxin, Humans, Drug Interactions
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!